Biotech

Sorry, we couldn't find any posts. Please try a different search.

Seven Finalists, including Ligocyte of Bozeman, Montana, Selected for The BioWest 2006 Venture Showcase Competition, Presenting World-Changing Technologies

LigoCyte (Bozeman, Montana) is a biopharmaceutical company focused on the development of therapeutic drugs and vaccines for preventing or treating human diseases within specialty markets.

LigoCyte Pharmaceuticals Awarded an Additional $2.3M Department of Defense Contract to Continue the Preclinical Development of Their 3rd Generation, Mucosal Anthrax Vaccine

The new vaccine provided 100% protection from an inhaled anthrax challenge in an animal study at Battelle Memorial Institute. "Our vaccine not only prevented death in all of the immunized animals, but it also reduced the morbidity, preventing the sickness caused by an infection," said Dr. Susan Wimer-Mackin, LigoCyte’s Director of Molecular Biology and the lead scientist on the anthrax vaccine project.

Montana State University scientists, and SpeciGen co-founders featured in cover article of Science

This is an exciting development because we can change viruses from disease-causing agents to disease-prevention and -detection agents.

Montana Bioscience Alliance meets Wednesday

Complete background on the Alliance can be found at the website http://www.montanabio.org. For more information about the Montana Bioscience Alliance or its annual meeting, contact Sharon Peterson at 896-5876 or [email protected].

SpeciGen’s Bio-Nanotechnology Featured in Cover Article in Science

Montana State University (MSU) scientists, and SpeciGen Inc.’s scientific co-founders, Drs. Mark Young and Trevor Douglas authored the cover article “Viruses: Making Friends With Old Foes” in the May 12th edition of the journal Science .

New Montana Biotechnology Company, SpeciGen Launched, Lonnie Bookbinder Selected as CEO

"SpeciGen uses patented, new and unique drug delivery vehicles to create and develop products for the diagnostic imaging and therapeutic marketplaces. Investing in SpeciGen is a way to help technology developed in Montana, stay in Montana and will allow SpeciGen to contribute to the state’s fledgling biomedical industry."

Renowned Stem Cell Researcher, Dr. Irving Weissman “Stem Cells: Science, Medicine and Politics”, 4/10, Missoula, MT

Weissman, an advocate for stem cell science, is director of the Institute of Cancer and Stem Cell Biology and Medicine at Stanford University and a professor in the school’s departments of developmental biology, pathology and biology.

Non-profit aids Arizona bioscience. Bolstering research, attracting firms are goals

Science Foundation Arizona is being created to attract private and public funding for biotech and biosciences, distribute the funds to key research efforts and lure new companies.

Sixty Pacific Northwest Life Science Companies to Present at Invest Northwest(C) 2006

Biotechnology, Medical Device and Bioinformatics Firms From Washington, British Columbia, Oregon, Alberta and Montana Selected to Present March 21-22 in Seattle

Fort Collins startup captures fast-pitch award

The emerging companies highlighted at the 2005 BioWest conference that started Tuesday:

MATR Sponsor (view all)


PFL Tech Inc. is a marketing technology company that provides sales enablement and marketing automation solutions, as well asprinting, mailing, and fulfillment services. They also provide some great Montana Jobs.

MATR Supporters (view all)


Big Sky EDA- Building Businesses and Creating Jobs in the Greater Billings, Montana area

Prospera helps businesses and communities find their pathway to success, acting as the navigator, problem solver and catalyst for a strong Montana economy.

Big Sky Commerce is an integrated provider of merchant credit card transaction processing services, check processing services, Internet payment gateways, related software application products and value-added services.